1. Academic Validation
  2. Friedelin Attenuates Neuronal Dysfunction and Memory Impairment by Inhibition of the Activated JNK/NF-κB Signalling Pathway in Scopolamine-Induced Mice Model of Neurodegeneration

Friedelin Attenuates Neuronal Dysfunction and Memory Impairment by Inhibition of the Activated JNK/NF-κB Signalling Pathway in Scopolamine-Induced Mice Model of Neurodegeneration

  • Molecules. 2022 Jul 14;27(14):4513. doi: 10.3390/molecules27144513.
Marva Sandhu 1 2 Hafiz Muhammad Irfan 1 Shahid Ali Shah 3 4 Madiha Ahmed 5 Iffat Naz 6 Muhammad Akram 1 Humaira Fatima 7 Ayesha Shuja Farooq 8
Affiliations

Affiliations

  • 1 College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
  • 2 Drugs Control and Traditional Medicines Division, NIH, Islamabad 45500, Pakistan.
  • 3 Department of Biology, The University of Haripur, Haripur 22620, Pakistan.
  • 4 Neuro Molecular Medicines Research Center (NMMRC), Peshawar 25000, Pakistan.
  • 5 Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad 44000, Pakistan.
  • 6 Department of Biology, Science Unit, Deanship of Educational Services, Qassim University, Buraidah 51452, Saudi Arabia.
  • 7 Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.
  • 8 Department of Biochemistry, Science Unit, Deanship of Educational Services, Qassim University, Buraidah 51452, Saudi Arabia.
Abstract

Oxidative stress (OS) and c-Jun N-terminal kinase (JNK) are both key indicators implicated in neuro-inflammatory signalling pathways and their respective neurodegenerative diseases. Drugs targeting these factors can be considered as suitable candidates for treatment of neuronal dysfunction and memory impairment. The present study encompasses beneficial effects of a naturally occurring triterpenoid, friedelin, against scopolamine-induced oxidative stress and neurodegenerative pathologies in mice models. The treated Animals were subjected to behavioural tests i.e., Y-maze and Morris water maze (MWM) for memory dysfunction. The underlying mechanism was determined via western blotting, antioxidant Enzymes and lipid profile analyses. Molecular docking studies were carried out to predict the binding modes of friedelin in the binding pocket of p-JNK protein. The results reveal that scopolamine caused oxidative stress by (1) inhibiting catalase (CAT), peroxidase Enzyme (POD), superoxide dismutase (SOD), and reduced glutathione Enzyme (GSH); (2) the up-regulation of thiobarbituric acid reactive substances (TBARS) in mice brain; and (3) affecting the neuronal synapse (both pre- and post-synapse) followed by associated memory dysfunction. In contrast, friedelin administration not only abolished scopolamine-induced oxidative stress, glial cell activation, and neuro-inflammation but also inhibited p-JNK and NF-κB and their downstream signaling molecules. Moreover, friedelin administration improved neuronal synapse and reversed scopolamine-induced memory impairment accompanied by the inhibition of β-secretase Enzyme (BACE-1) to halt amyloidogenic pathways of Amyloid-β production. In summary, all of the results show that friedelin is a potent naturally isolated neuro-therapeutic agent to reverse scopolamine-induced neuropathology, which is characteristic of Alzheimer's disease.

Keywords

Alzheimer’s disease; friedelin; neurodegeneration; oxidative stress; p-JNK; scopolamine; swiss albino mice.

Figures
Products